New pill could tame eye inflammation without needles
NCT ID NCT07552012
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an oral medication called FXS5626 in 40 adults with active non-infectious uveitis, a condition causing inflammation inside the eye. The goal is to see if the drug can control the disease better than a placebo, reducing the need for other treatments. Participants take the tablet daily for 24 weeks, and doctors monitor eye inflammation and safety.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACTIVE NON-ANTERIOR NON-INFECTIOUS UVEITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
EC of the First Affiliated Hospital of Chongqing Medical University
RECRUITINGChongqing, Chongqing Municipality, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.